Intercellular induction of apoptosis through modulation of endogenous survival factor concentration: A review

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 87-103

  Dormann, Sabine ^a   Schwieger, Agnes ^a   Hanusch, Jörg ^a   Häufel, Thomas ^a   Engelmann, Ilka ^a   Bauer, Georg ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Apoptosis; Fibroblasts; Intercellular communication; Survival factor; TGF beta

Indexed keywords

REACTIVE OXYGEN METABOLITE; SURVIVAL FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; CARCINOGENESIS; CELL COMMUNICATION; CELL TRANSFORMATION; FIBROBLAST; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; CELL COMMUNICATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; GENES, P53; HUMANS; PHENOTYPE; REACTIVE OXYGEN SPECIES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032945372     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Weinberg RA: Oncogenes, Antioncogenes and the molecular basis of multistep carcinogenesis. Cancer Res 49: 3713-3721, 1989.
2. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
3. Sporn MB and Todaro GJ: Autocrine secretion and malignant transformation of cells. New Eng J Medicine 303: 878-880, 1980.
4. Sporn MB and Roberts A: Autocrine growth factors and cancer. Nature 313: 745-747, 1985.
5. Browder TM, Dunbar CE and Nienhuls AW: Private and public autocrine loops in neoplastic cells. Cancer Cells 1: 9-17, 1989.
6. Lang RA and Burgess AW: Autocrine growth factors and tumorigenic transformation. Immunology Today 11: 244-249, 1990.
7. Wehrle I, Jakob A, Hofler P, and Bauer G: Transformation of murine fibroblasts by UV light and TGF-β: establishment of an autocrinc TGF-β loop. Int J Oncology 5: 1341-1346, 1994.
8. Cifone MA and Fidler IJ: Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. Proc Natl Acad Sci USA 77: 1039-1043, 1980.
9. Smith GJ, Bell WN, and Grisham JW: Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cell. Cancer Res 53: 500-508, 1993.
10. Hofler P, Wehrle I and Bauer G: TGF-beta induces an inhibitory effect of normal cells directed against transformed cells. Int J Cancer 54: 125-130, 1993.
11. Altenschmidt U, Moritz D and Groner B. Specific cytotoxic T lymphocytes in gene therapy. J Mol Medicine 75: 259-266, 1997.
12. Shu S, Plautz GE, Krauss JC, Chang AE: Tumor immunology. JAMA 278: 1972-1981, 1997.
13. Lindauer M, Stanislawski T, Hacussler A, Antunes E, Cellary A, Huber C and Theobald M: The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes. J Mol Medicine 76: 32-47, 1998.
14. Brittenden J, Heys SD, Ross J and Eremin O. Natural killer cells and cancer. Cancer 77: 1226-1243, 1996
15. Vujanovic N L, Basse P, Herbermann R B, Whiteside TL: Antitumor functions of natural killer cells and control of metastases. Methods 9: 394-408, 1996.
16. Mantovani A, Botazzi B, Coletta F, Sozzani S and Rucco L: The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270, 1992.
17. Bonta IL and Ben-Efraim S: Involvement of inflammatory mediators in macrophage antitumor activity. J Leukocyte Biol 54: 613-626, 1993.
18. Mehta PP, Bertram JS, and Loewenstein WR: Growth inhibition of transformed cells correlates with their junctional communication with normal cells. Cell 44: 187-196, 1986.
19. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW, and Giaccia AJ: Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91, 1996.
20. Kinzler KW and Vogelstein B: Life (and death) in a malignant tumour. Nature 379: 19-20, 1996.
21. Folkmann J: The role of angiogJenesis in tumor growth. Seminars in Cancer Biol 3: 65-71, 1992.
22. Gastl G, Helmann T, Steurer M, Zmija J, Gunsilius E, Unger C and Kraft A: Angiogenesis as a target for tumor treatment. Oncology 54: 177-184, 1997.
23. Wrann M, Bodmer S, de Martin R, Siepl C, Hofer-Warbinek R, Frei K, Hofer R and Fontana A: T-cell suppressor factor from human glioblastoma cells is a 12.5 kd protein closely related to transforming growth factor β. EMBO J 6: 1633-1636, 1987.
24. Rook AM, Kehrl JH, Wakefield LM, Roberts AB, Sporn, MB, Burlington DB, Lane HC and Fauci AS: Effects of transforming growth factor β on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsivness. J Immunol 136: 3916-3920, 1986.
25. Nagata S: Fas ligand and immune evasion. Nature (Medicine), 2: 1306-1307, 1996.
26. Stoker MGP, Shearer M, and O'Neill C: Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts. J Cell Sci 1: 297-310, 1966.
27. Martin W, Zempel G, Hulser D, and Willecke K: Growth inhibition of oncogene-transformed rat fibroblasts by cocultured normal cells: relevance of metabolic cooperation mediated by gap junctions. Cancer Res 51: 5348-5354, 1991.
28. Yotti LP, Chang CC, and Trosko JE: Elimination of metabolic cooperation in Chinese hamster cells by a tumor promoter. Science 206: 1089-1091, 1979.
29. Dotto GP, Parada LF, and Weinberg R. Specific growth response of ras-transformed embryo fibroblasts to tumor promoters. Nature 318: 472-475, 1985.
30. Enomoto T and Yamasaki H: Phorbol ester-mediated inhibition of intercellular communication in Balb/c3T3 cells. Relationship to enhancement of cell transformation. Cancer Res 445: 2681-2688, 1985.
31. Trosko J E and Chang CC: Oncogene and chemical inhibition of gap-junctional intercellular communication: implications for teratogenesis and carcinogenesis. Prog Clin Biol Res 209B: 21-31, 1986.
32. Trosko JE, Chang CC, Madhukar BV, and Klaunig J E: Chemical, oncogene and growth factor inhibition of gap junctional intercellular communication: an integrative hypothesis of carcinogenesis. Pathobiology 58: 265-278, 1990.
33. Silingardi P, Klein J-L, Mesnil M and Yamasaki H: Growth suppression of transformed Balb/c 3T3 cells by transforming growth factor β1 occurs only in the presence of their normal counterparts. Carcinogenesis 15: 1181-1185, 1994.
34. Boreiko CJ, Abernethy DJ, Rickert DE, Stedman DB: Effect of growth state, tumor promoters, and transformation upon intercellular comnunication between C3H/10T1/2 murine fibroblasts. Carcinogenesis 10: 113-121, 1989.
35. Fernandez A, Mondal S, and Heidelberger C: Probabalistic view of the transformation of cultured C3H 10 T1/2 mouse embryo fibroblasts by 3-methylcholanthrene. Proc Nat Acad Sci USA 77: 7272-7276, 1980.
36. Frazelle JH, Abemethy DJ, and Boreiko CJ: Factors influencing the promotion of transformation in chemically initiated C3H/10T1/2 C18 mouse embryo fibroblasts. Carcinogenesis 4: 709-715, 1983.
37. Frixen U and Yamasaki H: Enhancement of transformation and continuous inhibition of intercellular communication by 1-oleoyl-2-actyl glycerol in BALB/c 3T3 cells. Carcinogenesis 8: 1101-1104, 1987.
38. Haber DA, Fox DA, Dynan WS and Thilly WG: Cell density dependence of focus formation in the C3H/10T1/2 transformation assay. Cancer Res 37: 1644-1648, 1977.
39. Herschman HR and Brankow DW: Colony size, cell density and nature of the tumor promoter are critical variables in expression of a transformed phenotype (focus formation) in co-cultures of UV-TDTx and C3H10T1/2 cells. Carcinogenesis 8: 993-998, 1987.
40. Kakkanas A and Spandidos DA: In vitro and in vivo onco-suppressor activity of normal cells on cells transformed with the H-ras oncogene In Vivo 4: 109-114, 1990.
41. Schechtman LM, Kiss E, McCarvill J, Nims R, Kouri RE, and Lubet RA: A method for the amplification of chemically induced transformation in C3H/10T1/2 clone 8 cells: its use as a potential screening assay. JNCI 79: 487-498, 1987.
42. Bauer G (Invited Review): Elimination of transformed cells by normal cells: a novel concept for the control of carcinogenesis. Histol. Histopathol 11: 237-255, 1996.
43. Bauer G. Interference of papilloma viruses with p53-dependent and - independent apoptotic pathways: clues to viral oncogenesis (Review-Hypothesis). Oncology Rep 4: 273-275, 1997.
44. Yanagihara K and Tsumuraya M: Transforming growth factor beta-1 induces apoptotic cell death in human gastric carcinoma cells. Cancer Res 52: 4042-4045, 1992.
45. Wang CY, Eshleman JR, Willson JKV and Markovitz S: Both transforming growth factor beta and substrate release are inducers of apoptosis in a human colon adenoma cell line. Cancer Res 55: 5101-5105, 1995.
46. Mullauer L, Grasl Kraupp B, Bursch W, and Schulte Hermann R: Transforming growth factor beta-1-induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen. Hepatology 23: 840-847, 1996..
47. Lafron C, Mathieu C, Guerrin M, Pierre O, Vidal S and Valette A: Transforming growth factor beta-1-induced apoptosis in human ovarian carcinoma cells: Protection by the antioxidant N-acetylcysteine and bcl-2. Cell Growth and Differentiation 7: 1095-1104, 1996.
48. Yamamoto M, Maehara Y, Sakaguchi Y, Kusurnoto T, Ichiyoshi Y, Sugimachi K: Transforming growth factor-beta-1 induces apoptosis in gastric cancer cells through a p53-independent pathway. Cancer 77: 1628-1633, 1996.
49. Hsing AY, Kadomatsu K, Bonham MJ, and Danielpour D: Regulation of apoptosis induced by transforming growth factor-beta-1 in nontumorigenic and tumorigenic rat prostatic epithelial cell lines. Cancer Res 56: 5146-5149, 1996.
50. Gressner AM, Lahme B, Mannherz HG and Polzar B: TGF-beta-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatology 26: 1079-1092, 1997.
51. Buske C, Becker D, Feuring Buske M, Hannig H, Wulf G, Schaefer C, Hiddenmann W and Woermann B (1997) TGF-beta inhibits growth and induces apoptosis in leukemic B cell precursors. Leukemia 11: 386-392, 1997.
52. Jürgensmeier JM, Vicsel E, Hofler P and Bauer G: TGF-β-treated normal fibroblasts eliminate transformed fibroblasts by induction of apoptosis. Cancer Res 54: 393-398, 1494.
53. Bauer G: Resistance to TGF-β-induced elimination of transformed cells is required during tumor progression. Int J Oncol 6: 1227-1229, 1995.
54. Jürgensmeier J, Höfler P and Bauer G: TGF-β-induced elimination of transformed tibroblasts by normal cells: independence of cell-to-cell contact and dependence on ROS. Int J Oncology 5: 525-531, 1994.
55. Strauß SC, Weber M, Schächtele C and Bauer G: PKC-dependent and - independent cellular effects induced by recombinant transforming growth factor type beta. Int J Oncol 7: 565-572, 1995.
56. Panse J, Hipp ML and Bauer G: Fibroblasts transformed by chemical carcinogens are sensitive for intercellular induction of apoptosis: implications for the control of oncogenesis. Carcinogenesis 18: 259-264, 1997.
57. Hipp M L and Bauer G: Intercellular induction of apoptosis in transformed cells does not depend on p53. Oncogene 15: 791-797, 1997.
58. Eckert S and Bauer G: TGF-β isoforms and fibroblast growth factor exhibit analogous indirect antioncogenic activity through triggering of intercellular induction of apoptosis. Anticancer Res 18: 45-52, 1998.
59. Picht G, Hundertmark N, Schmitt C P and Bauer G: Clonal analysis of the effect of TGF-β on the apoptosis-inducing activity of normal cells. Exp Cell Res 218: 71-78, 1995.
60. Hackenjos K, Langer C, Zabel S and Bauer G: Transformed cells trigger induction of their own apoptosis in coculture with normal cells. Oncology Rep 3: 27-31, 1996.
61. Bassler D, Brauns H D and Bauer G: Role of proliferation for intercellular induction of apoptosis. Exp Cell Res 232: 349-352, 1997.
62. Langer C, Jürgensmeier JM and Bauer G: Reactive oxygen species act both at TGF-β-dependent and -independent steps during induction of apoptosis of transformed cells by normal cells. Exp Cell Res 222: 117-124, 1996.
63. Beck E, Schäfer R and Bauer G: Sensitivity of transformed fibroblasts for intercellular induction of apoptosis is determined by their transformed phenotype. Exp Cell Res 234: 47-56, 1997.
64. Melchinger W, Strauss S, Zucker B and Bauer G: Antiapoptotic activity of bovine papilloma virus: implications for the control of carcinogenesis. Int J Oncol 9: 927-933, 1996.
65. Jürgensmeier J and Bauer G: Interference of Bcl-2 with intercellular control of carcinogenesis. Int J Cancer 71: 698-704, 1997.
66. Ambrosini G, Adida C and Altieri D C: A novel anti-apoptotic gene, survivin, expressed in cancer and lymphoma. Nature 3: 917-921, 1997.
67. Schaefer D, Jürgensmeier J and Bauer G: Catechol interferes with TGF-β-induced elimination of transformed cells by normal cells: implications for the survival of transformed cells during carcinogenesis. Int J Cancer 60: 520-526, 1995.
68. Zucker B, Hanusch J and Bauer G: Glutathione depletion in fibroblasts is the basis for induction of apoptosis by endogenous reactive oxygen species. Cell Death and Differ 4: 388-395, 1997.
69. Zucker B and Bauer G: Intercellular induction of apoptosis of transformed cells is modulated by their intracellular glutathione concentration. Int J Oncol 10: 141-146, 1997.
70. Vaux DL: Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 90: 786-789, 1993.
71. Ishizaki Y, Cheng L, Mudge AW and Raff MC: Programmed cell death by default in embryonic cells, fibroblasts, and cancer cells. Mol Biol of the Cell 6: 1443-1458, 1995.
72. Godar GE: Preprogrammed cell death mechanisms of apoptosis: UV-induced immediate and delayed apoptosis. Photochemistry and Photobiology 63: 825-830, 1996.
73. Roth KA, Motoyama N, Loh DY: Apoptosis of bcl-x-deficient telencephalic cells in vitro. J Neuroscience 16: 1753-1758, 1996.
74. Preston GA, Lyon TT, Yin Y, Lang JE, Solomon G, Annab L, Srinivasan DG, Alcorta DA and Barrett JC: Induction of apoptosis by c-fos protein. Mol Cell Biol 16: 211-218, 1996.
75. Ledda-Columbano GM, Coni P, Faa G, Manenti G, Columbano A: Rapid induction of apoptosis in rat liver by cycloheximide. Am J Pathol 140: 545-549, 1992.
76. Ishii H, Etheridge MR and Gobe GC: Cycloheximide-induced apoptosis in Burkitt lymphoma (BJA-B cells with and without Epstein-Barr virus infection. Immunol and Cell Biol 73: 463-468, 1995.
77. Lindenboim L, Haviv R and Stein R: Inhibition of drug-induced apoptosis by survival factors in PC12 cells. J Neurochemistry 64: 1054-1063, 1995.
78. Polunovsky VA, Wenst CH, Ingbar DH, Peterson MS and Bitterman PB: Induction of endothelial cells apoptosis by TNF-alpha: Modulation by inhibitors of protein synthesis. Exp Cell Res 214: 584-594, 1994.
79. Waring P: DNA fragmentation induced in macrophages by gliotoxin does not require protein synthesis and is preceded by raised inositol triphosphate levels. J Biol Chem 265: 14476-14480, 1990.
80. Gong J, Li X and Darzynkiewicz Z: Different patterns of apoptosis of HL-60 cells induced by cycloheximide and campothecin. J Cell Physiol 157: 263-270, 1993.
81. Martin SJ, Lennon SV, Bonham AM and Cotter TG: Induction of apoptosis (programmed cell death in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 145: 1859-1867, 1990.
82. Weil M, Jacobson MD, Coles H S R, Davies TJ, Gardner RL, RaffK D 38 and Raff, MC: Constitutive expression of the machinery for programmed cell death. Journal of Cell Biology 133: 1053-1059, 1996.
83. Huang RP, Wu JX, Fan Y and Adamson ED: UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol 133: 211-220, 1996.
84. Barcellos Hoff MH and Dix TA: Redox-mediated activation of latent transforming growth factor-beta-1. Molecular Endocrinology 10: 1077-1083, 1996.
85. Yao Y, Yin D, Jas GS, Kuczera K, Williams TD, Schoneich C and Squier TC: Oxydative modification of a carboxyl-terminal vicinal methionine in calmodulin by hydrogen peroxide inhibits calmodulin-dependent activation of the plasma membrane Ca-ATPase. Biochemistry 35: 2767-2787, 1996.
86. Ermacora MR, Delfino JM, Cuenoud B, Schepartz A and Fox RO: Conformation-dependent cleavage of staphylococcal nuclease with a disulfide linked iron chelate. Proc Natl Acad Sci USA 89: 6383-6387, 1992.
87. Weichsel A, Gadaska JR, Powis G and Montfort WR: Crystal structures of reduced, oxidized, and mutated human thioredoxins: Evidence for a regulatory homodimer. Structure 4: 735-751, 1996.
88. Wittung P and Malmstrom BG: Redox-linked conformational changes in cytochrom c oxidase. FEBS Letters 388: 47-49, 1996.
89. Hainaut P and Milner J: Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res 53: 4469-4473, 1993.
90. Myrset AH, Bostad A, Jamin N, Lirsac P-N, Toma F and Gabrielson OS: DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein. EMBO J 12: 4625-4633, 1993.
91. Li D, Stevens FJ, Schiffer M and Anderson LE: Mechanism of light modulation: Identification of potential redox-sensitive cysteines distal to catalytic site in light-activated chloroplast enzymes. Biophysical J 67: 29-35, 1994.
92. Storz G, Tartaglia LA and Ames BN: Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxidation. Science 248: 189-194, 1990.
93. Bronner MP, Cullin C, Reed JC, and Furth EE: The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am J Path 146: 20-26, 1995.
94. Gaukroger JM, Bradley A, Chadrachud L, Jarrett WFH and Campo MS: Interaction between bovine papillomavirus type 4 and cocarcinogens in the production of malignant tumours. J Gen Virol 74: 2275-2280, 1993.
95. Jackson ME, Campo MS, and Gaukroger JM: Cooperation between papillomaviruses and chemical cofactors in oncogenesis. Crit Rev in Oncogenesis 4: 277-291, 1993.
96. Pathmanathan R, Prasad U, Sadler R, Flynn K, and Raab-Traub N: Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. New Engl J Med 333: 693-698, 1995.
97. Lindeberg H and Elbrond O: Malignant tumours in patients with a history of multiple laryngeal papillomas: the significance of irradiation. Clin Otolaryngol 16: 149-151, 1991.
98. Mikhailowski R, Shpitz B, Polak-Charcon S, Kost Y, Segal C, Fich A and Lamprecht SA: Controlled release of TGF-beta1 impedes rat colon carcinogenesis in vivo. Int J Cancer, in press.
99. Gorczyca W, Gong J and Darzynkiewicz Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53: 1945-1951, 1993.
100. Vossbeck H, Strahm B, Hofler P and Bauer G: Direct transforming activity of TGF-β on rat fibroblasts. Int J Cancer 61: 92-97, 1995.